Suraksha Diagnostic Limited Stock Price Today (NSE: SURAKSHA)
Fundamental Score
Suraksha Diagnostic Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Suraksha Diagnostic Limited share price today is ₹317.85, down 0.14% on NSE/BSE as of 25 August 2026. Suraksha Diagnostic Limited (SURAKSHA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹1.36K (Cr). The 52-week high for SURAKSHA share price is ₹333.00 and the 52-week low is ₹224.10. At a P/E ratio of 37.97x, SURAKSHA is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 14.11% and a debt-to-equity ratio of 0.01.
Suraksha Diagnostic Limited Share Price Chart — NSE/BSE Historical Performance
Suraksha Diagnostic Limited share price chart: 27.34% return over the past month. 52-week high ₹333.00, 52-week low ₹224.10.
Suraksha Diagnostic Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹323.10 | ₹324.20 | ₹313.10 | ₹317.85 | 73.14K (Cr) | |
| ₹309.50 | ₹323.45 | ₹309.50 | ₹318.30 | 2.40L (Cr) | |
| ₹303.00 | ₹308.00 | ₹296.60 | ₹304.90 | 2.87L (Cr) | |
| ₹280.00 | ₹312.00 | ₹272.00 | ₹304.45 | 38.87L (Cr) | |
| ₹259.90 | ₹272.00 | ₹259.85 | ₹270.35 | 2.03L (Cr) | |
| ₹265.00 | ₹277.70 | ₹257.50 | ₹258.25 | 3.94L (Cr) | |
| ₹250.00 | ₹281.85 | ₹250.00 | ₹265.50 | 8.20L (Cr) | |
| ₹250.05 | ₹253.85 | ₹247.00 | ₹249.55 | 20.82K (Cr) | |
| ₹252.30 | ₹254.85 | ₹249.20 | ₹250.75 | 32.68K (Cr) | |
| ₹254.80 | ₹259.90 | ₹251.00 | ₹252.30 | 21.71K (Cr) |
Suraksha Diagnostic Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹253.00 | ₹324.20 | ₹247.00 | ₹317.85 | +25.63% | |
| ₹272.00 | ₹281.50 | ₹246.75 | ₹252.15 | -7.30% | |
| ₹286.00 | ₹301.00 | ₹255.00 | ₹272.95 | -4.56% | |
| ₹280.00 | ₹324.95 | ₹280.00 | ₹285.80 | +2.07% | |
| ₹230.99 | ₹292.10 | ₹230.99 | ₹283.95 | +22.93% | |
| ₹240.00 | ₹276.00 | ₹224.10 | ₹227.95 | -5.02% | |
| ₹270.20 | ₹293.95 | ₹265.00 | ₹271.45 | +0.46% | |
| ₹270.55 | ₹281.65 | ₹251.50 | ₹265.95 | -1.70% | |
| ₹290.75 | ₹299.90 | ₹264.05 | ₹269.65 | -7.26% | |
| ₹315.15 | ₹329.00 | ₹286.00 | ₹292.70 | -7.12% | |
| ₹297.00 | ₹325.90 | ₹284.20 | ₹317.95 | +7.05% | |
| ₹296.80 | ₹333.00 | ₹295.00 | ₹298.35 | +0.52% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Suraksha Diagnostic Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Suraksha Diagnostic Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SURAKSHA across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Excellent ROCE Performance (16.82%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (30.09%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (38.42%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (20.75%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Cash Generation (₹120.33 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 36.60%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
2 factors identified
High Price-to-Book Ratio (5.55x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Suraksha Diagnostic Limited vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Suraksha Diagnostic Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Suraksha Diagnostic LimitedSuraksha Diagno...Selected✓ SURAKSHA • 544293 | 56.2/100 | ₹317.85₹318 | ₹1359.30₹1359.30 | 37.97Average 38.0 Average | 14.11%Average 14.11% Average | 16.82%Good 16.82% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% |
Dr. Lal Path Labs Ltd.Dr. Lal Path La... LALPATHLAB • 539524 | 57.7/100 | ₹1913.70₹1914 | ₹28908.91₹28908.91 | 53.35Average 53.3 Average | 21.57%Excellent 21.57% Excellent | 27.62%Excellent 27.62% Excellent | 0.00Excellent 0.0 Excellent | 11.60%Good 11.60% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LimitedVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1483.40₹1483 | ₹14307.85₹14307.85 | 76.31Average 76.3 Average | 19.74%Good 19.74% Good | 21.32%Excellent 21.32% Excellent | 0.00Excellent 0.0 Excellent | — — | — — | 0.14% |
Metropolis Healthcare LimitedMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹566.70₹567 | ₹11858.49₹11858.49 | 58.81Average 58.8 Average | 13.36%Average 13.36% Average | 16.80%Good 16.80% Good | 0.01Excellent 0.0 Excellent | 0.74%Average 0.74% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LimitedThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹596.05₹596 | ₹8420.27₹8420.27 | 47.76Average 47.8 Average | 28.80%Excellent 28.80% Excellent | 35.47%Excellent 35.47% Excellent | 0.00Excellent 0.0 Excellent | — — | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LimitedKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹564.80₹565 | ₹1777.47₹1777.47 | 21.62Average 21.6 Average | 10.89%Average 10.89% Average | 13.05%Average 13.05% Average | 0.55Good 0.5 Good | — — | — — | 0.50% |
One Global Service Provider LimitedOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹546.20₹546 | ₹1178.25₹1178.25 | — — | — — | — — | — — | — — | — — | 0.00% |
3B Blackbio Dx Limited3B Blackbio Dx ... 3BBLACKBIO • 532067 | 60.3/100 | ₹1262.40₹1262 | ₹1079.13₹1079.13 | — — | — — | — — | — — | — — | — — | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹220.15₹220 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Aspira Pathlab & Diagnostics LimitedAspira Pathlab ... ASPIRA • 540788 | 11.9/100 | ₹93.70₹94 | ₹88.52₹88.52 | 1770.34Average 1770.3 Average | 0.51%Poor 0.51% Poor | 2.84%Poor 2.84% Poor | 0.27Excellent 0.3 Excellent | -48.50%Poor -48.50% Poor | 10.43%Good 10.43% Good | 0.00% |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr. Lal Path Labs Ltd. share price28908.91 Cr
- Vijaya Diagnostic Centre Limited share price14307.85 Cr
- Metropolis Healthcare Limited share price11858.49 Cr
- Thyrocare Technologies Limited share price8420.27 Cr
- Krsnaa Diagnostics Limited share price1777.47 Cr
Suraksha Diagnostic Limited PE Ratio History
Historical price-to-earnings ratio for SURAKSHA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹5.97 | ₹269.65 | 45.2x |
| FY 2024 | ₹4.54 | ₹375.65 | 82.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Suraksha Diagnostic Limited Quarterly Performance
Latest quarterly metrics for SURAKSHA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
20.75%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
38.42%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Suraksha Diagnostic Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SURAKSHA — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Suraksha Diagnostic Limited Financial Statements
Annual income statement, balance sheet and cash flow for Suraksha Diagnostic Limited (SURAKSHA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Suraksha Diagnostic Limited
About SURAKSHA (Suraksha Diagnostic Limited)
Suraksha Diagnostic Ltd is a comprehensive healthcare service provider dedicated to delivering accurate, reliable, and timely diagnostic testing to patients across India. As a trus...ted name in the diagnostic landscape, Suraksha is committed to utilizing state-of-the-art technology and employing highly skilled professionals to ensure the highest standards of quality. From routine blood tests to advanced imaging, Suraksha offers a broad spectrum of diagnostic services to cater to the diverse needs of its patients and healthcare partners. Driven by a patient-centric approach, Suraksha aims to empower individuals to make informed decisions about their health through accessible and affordable diagnostic solutions. Suraksha Diagnostic's commitment extends beyond simply providing testing services. They are dedicated to employing cutting-edge methodologies and sophisticated equipment to analyze biological samples and produce detailed images. Specifically, the pathology department examines blood, tissues, and other body fluids using a range of techniques, from traditional staining methods to advanced molecular diagnostics. The radiology department utilizes sophisticated imaging equipment, like MRI and CT scans, to provide detailed views of internal organs and structures. This dedication to technology and expertise allows Suraksha to play a crucial role in early disease detection, accurate diagnosis, and effective treatment planning. In addition to its technical prowess, Suraksha Diagnostic prides itself on its unwavering commitment to ethical practices, patient safety, and customer satisfaction. The company adheres to stringent quality control measures and participates in external quality assurance programs to ensure the accuracy and reliability of its test results. Suraksha strives to create a welcoming and comfortable environment for its patients, with a focus on personalized attention and compassionate care. By combining cutting-edge technology with a human touch, Suraksha Diagnostic is committed to being a trusted partner in promoting the health and well-being of the communities it serves.
Company Details
Key Leadership
SURAKSHA Share Price: Frequently Asked Questions
What is the current share price of Suraksha Diagnostic Limited?
Suraksha Diagnostic Limited (SURAKSHA) trades at ₹317.85 on NSE and BSE. Market cap ₹1.36K (Cr). Educational data only.
What is the P/E ratio of Suraksha Diagnostic Limited?
Suraksha Diagnostic Limited has a P/E of 37.97x vs industry average 42.23x.
What is the Bull Run score for Suraksha Diagnostic Limited?
Suraksha Diagnostic Limited has a Bull Run score of 56.2/100 based on 25+ financial parameters.
Does Suraksha Diagnostic Limited pay dividends?
Suraksha Diagnostic Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Suraksha Diagnostic Limited?
Suraksha Diagnostic Limited has ROE of 14.11%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Suraksha Diagnostic Limited?
Suraksha Diagnostic Limited has debt-to-equity of 0.01.
Is Suraksha Diagnostic Limited a good investment?
Bull Run gives Suraksha Diagnostic Limited a score of 56.2/100. This is not investment advice — consult a SEBI-registered advisor.